TheraPsil, a B.C.-based non-profit, has launched its first-ever research collaboration as it continues to advocate for the legalization of psilocybin for medical purposes. In collaboration with researchers from McGill University and the Centre for Psychedelic Research at Imperial College London, the quantitative research study aims to understand the impact of psilocybin-assisted psychotherapy on Canadian patients who experience end-of-life distress.
Share this post
